Literature DB >> 32938767

Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.

Yuepeng Liu1,2, Li Dai3, Junhua Dong1,2, Cen Chen1,2, Jingen Zhu3, Venigalla B Rao4, Pan Tao5,2.   

Abstract

The interplay between defense and counterdefense systems of bacteria and bacteriophages has been driving the evolution of both organisms, leading to their great genetic diversity. Restriction-modification systems are well-studied defense mechanisms of bacteria, while phages have evolved covalent modifications as a counterdefense mechanism to protect their genomes against restriction. Here, we present evidence that these genome modifications might also have been selected to counter, broadly, the CRISPR-Cas systems, an adaptive bacterial defense mechanism. We found that the phage T4 genome modified by cytosine hydroxymethylation and glucosylation (ghmC) exhibits various degrees of resistance to the type V CRISPR-Cas12a system, producing orders of magnitude more progeny than the T4(C) mutant, which contains unmodified cytosines. Furthermore, the progeny accumulated CRISPR escape mutations, allowing rapid evolution of mutant phages under CRISPR pressure. A synergistic effect on phage restriction was observed when two CRISPR-Cas12a complexes were targeted to independent sites on the phage genome, another potential countermechanism by bacteria to more effectively defend themselves against modified phages. These studies suggest that the defense-counterdefense mechanisms exhibited by bacteria and phages, while affording protection against one another, also provide evolutionary benefits for both.IMPORTANCE Restriction-modification (R-M) and CRISPR-Cas systems are two well-known defense mechanisms of bacteria. Both recognize and cleave phage DNA at specific sites while protecting their own genomes. It is well accepted that T4 and other phages have evolved counterdefense mechanisms to protect their genomes from R-M cleavage by covalent modifications, such as the hydroxymethylation and glucosylation of cytosine. However, it is unclear whether such genome modifications also provide broad protection against the CRISPR-Cas systems. Our results suggest that genome modifications indeed afford resistance against CRISPR systems. However, the resistance is not complete, and it is also variable, allowing rapid evolution of mutant phages that escape CRISPR pressure. Bacteria in turn could target more than one site on the phage genome to more effectively restrict the infection of ghmC-modified phage. Such defense-counterdefense strategies seem to confer survival advantages to both the organisms, one of the possible reasons for their great diversity.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CRISPR-Cas; bacteriophage; genome modification; phage T4; restriction-modification system

Mesh:

Substances:

Year:  2020        PMID: 32938767      PMCID: PMC7654273          DOI: 10.1128/JVI.01630-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Revenge of the phages: defeating bacterial defences.

Authors:  Julie E Samson; Alfonso H Magadán; Mourad Sabri; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2013-08-27       Impact factor: 60.633

Review 2.  (Ph)ighting Phages: How Bacteria Resist Their Parasites.

Authors:  Jakob T Rostøl; Luciano Marraffini
Journal:  Cell Host Microbe       Date:  2019-02-13       Impact factor: 21.023

Review 3.  Diverse functions of restriction-modification systems in addition to cellular defense.

Authors:  Kommireddy Vasu; Valakunja Nagaraja
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

4.  Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.

Authors:  Alexander P Hynes; Manuela Villion; Sylvain Moineau
Journal:  Nat Commun       Date:  2014-07-24       Impact factor: 14.919

5.  High abundance of viruses found in aquatic environments.

Authors:  O Bergh; K Y Børsheim; G Bratbak; M Heldal
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

Review 6.  Diversity, classification and evolution of CRISPR-Cas systems.

Authors:  Eugene V Koonin; Kira S Makarova; Feng Zhang
Journal:  Curr Opin Microbiol       Date:  2017-06-09       Impact factor: 7.934

Review 7.  Initiation of bacteriophage T4 DNA replication and replication fork dynamics: a review in the Virology Journal series on bacteriophage T4 and its relatives.

Authors:  Kenneth N Kreuzer; J Rodney Brister
Journal:  Virol J       Date:  2010-12-03       Impact factor: 4.099

8.  CRISPR/Cas9-mediated phage resistance is not impeded by the DNA modifications of phage T4.

Authors:  Stephanie J Yaung; Kevin M Esvelt; George M Church
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

9.  The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.

Authors:  Bruce R Levin; Sylvain Moineau; Mary Bushman; Rodolphe Barrangou
Journal:  PLoS Genet       Date:  2013-03-14       Impact factor: 5.917

10.  Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.

Authors:  Pan Tao; Xiaorong Wu; Venigalla Rao
Journal:  Sci Adv       Date:  2018-02-14       Impact factor: 14.136

View more
  6 in total

1.  CRISPR Engineering of Bacteriophage T4 to Design Vaccines Against SARS-CoV-2 and Emerging Pathogens.

Authors:  Jingen Zhu; Neeti Ananthaswamy; Swati Jain; Himanshu Batra; Wei-Chun Tang; Venigalla B Rao
Journal:  Methods Mol Biol       Date:  2022

2.  A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering.

Authors:  Jingen Zhu; Neeti Ananthaswamy; Swati Jain; Himanshu Batra; Wei-Chun Tang; Douglass A Lewry; Michael L Richards; Sunil A David; Paul B Kilgore; Jian Sha; Aleksandra Drelich; Chien-Te K Tseng; Ashok K Chopra; Venigalla B Rao
Journal:  Sci Adv       Date:  2021-09-08       Impact factor: 14.957

Review 3.  Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review.

Authors:  Siyu Liu; Hongyun Lu; Shengliang Zhang; Ying Shi; Qihe Chen
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.321

Review 4.  Intestinal phages interact with bacteria and are involved in human diseases.

Authors:  Han Shuwen; Ding Kefeng
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.

Authors:  Jingen Zhu; Swati Jain; Jian Sha; Himanshu Batra; Neeti Ananthaswamy; Paul B Kilgore; Emily K Hendrix; Yashoda M Hosakote; Xiaorong Wu; Juan P Olano; Adeyemi Kayode; Cristi L Galindo; Simran Banga; Aleksandra Drelich; Vivian Tat; Chien-Te K Tseng; Ashok K Chopra; Venigalla B Rao
Journal:  mBio       Date:  2022-07-28       Impact factor: 7.786

6.  Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair.

Authors:  Xiaorong Wu; Jingen Zhu; Pan Tao; Venigalla B Rao
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.